Novel gene therapy offers hope for hearing loss associated with ageing
In the US, one third of adults aged between 64 and 75 suffer from age-related hearing loss. Around half of this number is due to genetics.
This type of hearing loss is also extremely difficult to treat because it involves a complex genetic toolkit.
Researchers have for the first targeted age-related hearing loss in a cohort of older mice that had a mutation in the human transmembrane serine protease gene (TMPRSS3), which results in autosomal dominant deafness (DFNB8/DFNB10).
Source:
https://newatlas.com/medical/age-related-hearing-loss-novel-gene-therapy/
